Cite
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
MLA
Sperduto, Paul W., et al. “Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-MolGPA).” International Journal of Radiation Oncology, Biology, Physics, vol. 99, no. 4, Nov. 2017, pp. 812–16. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2017.06.2454.
APA
Sperduto, P. W., Jiang, W., Brown, P. D., Braunstein, S., Sneed, P., Wattson, D. A., Shih, H. A., Bangdiwala, A., Shanley, R., Lockney, N. A., Beal, K., Lou, E., Amatruda, T., Sperduto, W. A., Kirkpatrick, J. P., Yeh, N., Gaspar, L. E., Molitoris, J. K., Masucci, L., … Mehta, M. (2017). Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). International Journal of Radiation Oncology, Biology, Physics, 99(4), 812–816. https://doi.org/10.1016/j.ijrobp.2017.06.2454
Chicago
Sperduto, Paul W, Wen Jiang, Paul D Brown, Steve Braunstein, Penny Sneed, Daniel A Wattson, Helen A Shih, et al. 2017. “Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-MolGPA).” International Journal of Radiation Oncology, Biology, Physics 99 (4): 812–16. doi:10.1016/j.ijrobp.2017.06.2454.